SCHEMBL9944396

SCHEMBL9944396

O=S(=O)(O)CCC1CC2CCC1C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 2/20 0.39
POLB P06746 1/20 0.34
EPHX1 P07099 1/20 0.34
INPP5A Q14642 1/20 0.32
HPGD P15428 2/20 0.32
P2RX7 Q99572 1/20 0.32
PER2 O15055 1/20 0.32
CRY1 Q16526 1/20 0.32
CRY2 Q49AN0 1/20 0.32
MEP1B Q16820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18775645 0.89 CYP1A2 (0.38) HSD17B10CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL13005302 0.80 INPP5A (0.47) HSD17B10CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL25233759 0.76 MEN1 (0.41) MEN1KMT2ANPC1RAB9AEPHX2
SCHEMBL18403046 0.76 MEN1 (0.34) MEN1KMT2ANPC1RAB9AP2RX7
SCHEMBL10172863 0.74 MEN1 (0.45) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL18785775 0.74 CYP1A2 (0.35) HSD17B10CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL18775721 0.74 MEN1 (0.38) HSD17B10CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL23781764 0.74 CYP1A2 (0.38) HSD17B10CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL10835600 0.73 NPC1 (0.42) HSD17B10MEN1KMT2ANPC1RAB9A
SCHEMBL222555 0.73 MEN1 (0.41) HSD17B10CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11822240-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2023-11-21 US disclosed
US-11747726-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2023-09-05 US disclosed
WO-2023153296-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMATION METHOD JSR株式会社 2023-08-17 WO disclosed
US-11709425-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2023-07-25 US disclosed
US-11635686-B2 Resist composition, method of forming resist pattern, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2023-04-25 US disclosed
US-20220121118-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2022-04-21 US disclosed
US-11221557-B2 Resist composition, method of forming resist pattern, compound, and acid generator TOKYO OHKA KOGYO CO., LTD. (JP) 2022-01-11 US disclosed
US-20210397086-A1 RESIST COMPOSITION AND RESIST PATTERN FORMING METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2021-12-23 US disclosed
US-11204551-B2 Resist composition and method for forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2021-12-21 US disclosed
US-20210200087-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2021-07-01 US disclosed
US-20120015299-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR TOKYO OHKA KOGYO CO., LTD. (JP) 2012-01-19 US disclosed
US-8012669-B2 Resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2011-09-06 US disclosed
US-20110117499-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN USING THE SAME, AND FLUORINE-CONTAINING POLYMERIC COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2011-05-19 US disclosed
US-7914968-B2 Positive resist composition and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2011-03-29 US disclosed
US-20100304289-A1 POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2010-12-02 US disclosed
US-20100273106-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2010-10-28 US disclosed
US-20100233626-A1 POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2010-09-16 US disclosed
US-20100233624-A1 POSITIVE RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2010-09-16 US disclosed
US-20100035192-A1 METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2010-02-11 US disclosed
US-20090226842-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11709425-B2 Resist composition and method of forming resist pattern RER1, RRS1, RXFP4 HSD17B10 661/4885CYP1A2 717/4885CYP2D6 950/4885
US-20120015299-A1 RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, NOVEL COMPOUND, AND ACID GENERATOR RER1, ASIC1, ABCC1 HSD17B10 305/4885CYP1A2 379/4885CYP2D6 1449/4885
US-20100273106-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND RDX, DAD1, DDX1 HSD17B10 2909/4885CYP1A2 2875/4885CYP2D6 4184/4885
US-11635686-B2 Resist composition, method of forming resist pattern, and compound FXR1, HNRNPA1, RBM3 HSD17B10 3497/4885CYP1A2 2965/4885CYP2D6 2622/4885
US-11221557-B2 Resist composition, method of forming resist pattern, compound, and acid generator RER1, GRM1, RRS1 HSD17B10 1461/4885CYP1A2 1000/4885CYP2D6 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.